Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Jaffee

Showing results (81-90 of 291) with videos related to

Pageof 30
Sort By:
Cancer Research|November 4, 2024
Correction: Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic BiomarkersHaoyang Mi, Shamilene Sivagnanam, Courtney B Betts, et al.
Cancer Research|September 16, 2022
Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic BiomarkersHaoyang Mi, Shamilene Sivagnanam, Courtney B Betts, et al.
Annals of the New York Academy of Sciences|April 5, 2019
Anti-CTLA-4 synergizes with dendritic cell-targeted vaccine to promote IL-3-dependent CD4<sup>+</sup> effector T cell infiltration into murine pancreatic tumorsNeeha Zaidi, Sergio A Quezada, Janelle M Y Kuroiwa, et al.
Journal of Translational Medicine|May 17, 2011
Review of the 25th annual scientific meeting of the International Society for Biological Therapy of CancerJames M Balwit, Pawel Kalinski, Vernon K Sondak, et al.
Oncotarget|October 31, 2015
TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent mannerKevin C Soares, Agnieszka A Rucki, Victoria Kim, et al.
International Journal of Cancer|September 22, 2010
CD8⁺ Foxp3⁺ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor responseDung T Le, Brian H Ladle, Timothy Lee, et al.
Trends in Molecular Medicine|March 14, 2026
Recent developments in cancer immuno-interception strategiesZirui Zhu, Jocelyn Mathew, Benjamin Barrett, et al.
JCI Insight|September 4, 2020
Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine developmentNeeha Zaidi, Mariya Soban, Fangluo Chen, et al.
International Journal of Cancer|November 28, 2002
Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivoStephan R Scheffer, Heike Nave, Firouzeh Korangy, et al.
Human Gene Therapy|July 30, 2003
Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cellsXianzheng Zhou, Yan Cui, Xin Huang, et al.
Pageof 30

Showing results (81-90 of 291) with videos related to

Sort By:
Pageof 30
Cancer Research|November 4, 2024
Correction: Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic BiomarkersHaoyang Mi, Shamilene Sivagnanam, Courtney B Betts, et al.
Cancer Research|September 16, 2022
Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic BiomarkersHaoyang Mi, Shamilene Sivagnanam, Courtney B Betts, et al.
Annals of the New York Academy of Sciences|April 5, 2019
Anti-CTLA-4 synergizes with dendritic cell-targeted vaccine to promote IL-3-dependent CD4<sup>+</sup> effector T cell infiltration into murine pancreatic tumorsNeeha Zaidi, Sergio A Quezada, Janelle M Y Kuroiwa, et al.
Journal of Translational Medicine|May 17, 2011
Review of the 25th annual scientific meeting of the International Society for Biological Therapy of CancerJames M Balwit, Pawel Kalinski, Vernon K Sondak, et al.
Oncotarget|October 31, 2015
TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent mannerKevin C Soares, Agnieszka A Rucki, Victoria Kim, et al.
International Journal of Cancer|September 22, 2010
CD8⁺ Foxp3⁺ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor responseDung T Le, Brian H Ladle, Timothy Lee, et al.
Trends in Molecular Medicine|March 14, 2026
Recent developments in cancer immuno-interception strategiesZirui Zhu, Jocelyn Mathew, Benjamin Barrett, et al.
JCI Insight|September 4, 2020
Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine developmentNeeha Zaidi, Mariya Soban, Fangluo Chen, et al.
International Journal of Cancer|November 28, 2002
Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivoStephan R Scheffer, Heike Nave, Firouzeh Korangy, et al.
Human Gene Therapy|July 30, 2003
Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cellsXianzheng Zhou, Yan Cui, Xin Huang, et al.
Pageof 30